These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 8494782
1. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Wu SP, Sun LZ, Willson JK, Humphrey L, Kerbel R, Brattain MG. Cell Growth Differ; 1993 Feb; 4(2):115-23. PubMed ID: 8494782 [Abstract] [Full Text] [Related]
8. Autocrine TGFalpha expression in the regulation of initiation of human colon carcinoma growth. Wang D, Li W, Jiang W, Humphrey LE, Howell GM, Brattain MG. J Cell Physiol; 1998 Dec; 177(3):387-95. PubMed ID: 9808147 [Abstract] [Full Text] [Related]
9. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. Zipfel PA, Ziober BL, Morris SL, Mulder KM. Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905 [Abstract] [Full Text] [Related]
10. Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells. Yang H, Kyo S, Takatura M, Sun L. Cell Growth Differ; 2001 Feb; 12(2):119-27. PubMed ID: 11243466 [Abstract] [Full Text] [Related]
11. The role of transforming growth factor alpha in determining growth factor independence. Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, Howell GM. Cancer Res; 2003 Aug 01; 63(15):4731-8. PubMed ID: 12907656 [Abstract] [Full Text] [Related]
16. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells. Periyasamy S, Sun L, Gentry LE, Brattain MG. J Cell Physiol; 1996 Sep 01; 168(3):711-20. PubMed ID: 8816926 [Abstract] [Full Text] [Related]
17. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells. Jiang W, Tillekeratne MP, Brattain MG, Banerji SS. Biochemistry; 1997 Dec 02; 36(48):14786-93. PubMed ID: 9402753 [Abstract] [Full Text] [Related]
18. Phenotypic consequences of transforming growth factor beta1 gene ablation in murine embryonic fibroblasts: autocrine control of cell proliferation and extracellular matrix biosynthesis. Sudarshan C, Yaswen L, Kulkarni A, Raghow R. J Cell Physiol; 1998 Jul 02; 176(1):67-75. PubMed ID: 9618146 [Abstract] [Full Text] [Related]
19. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells. Kutz SM, Providence KM, Higgins PJ. Cell Motil Cytoskeleton; 2001 Mar 02; 48(3):163-74. PubMed ID: 11223948 [Abstract] [Full Text] [Related]
20. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA. Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181 [Abstract] [Full Text] [Related] Page: [Next] [New Search]